PPS-TLR7/8 agonist nanoparticles equip robust anticancer immunity by selectively prolonged activation of dendritic cells
Yingxi Zhang, Yicheng Li, Zhaochu Xu, Linyi Xu, Yue Wang, Yue Wang, Ning Li, Nicholas C. Solek, Yongjun Wang, Yongjun Wang, Bowen Li, Hongzhuo Liu, Bowen Li, Hongzhuo Liu
Topics & Concepts
TLR7AgonistMaterials scienceNanoparticleImmunityDendritic cellPharmacologyNanotechnologyCancer researchBiophysicsImmune systemInnate immune systemReceptorImmunologyMedicineBiologyToll-like receptorInternal medicineImmunotherapy and Immune ResponsesRNA Interference and Gene DeliveryNanoplatforms for cancer theranostics